LEVETIRACETAM TEVA ® 250 MG

מדינה: ישראל

שפה: אנגלית

מקור: Ministry of Health

מרכיב פעיל:

LEVETIRACETAM 250 MG

זמין מ:

TEVA PHARMACEUTICAL INDUST.LTD

קוד ATC:

N03AX14

טופס פרצבטיות:

TABLETS

מסלול נתינה (של תרופות):

PER OS

תוצרת:

TEVA PHARMACEUTICAL INDUSTRIES LTD

קבוצה תרפויטית:

LEVETIRACETAM

סממני תרפויטית:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

תאריך אישור:

2009-09-01